The Short Report

CAPR
Capricor Therapeutics, Inc.

1 report on Capricor Therapeutics, Inc. (CAPR) by BMF Reports, summarized: the thesis, evidence and key numbers. Latest: Aug 17, 2026.

No spam. Unsubscribe anytime.

All Reports CAPR × / Market Intelligence

CAPR

1 of 1 reports
CAPR —
—
CAPR Capricor Therapeutics, Inc.

Capricor Therapeutics (NASDAQ: $CAPR): Turned a Rare Disease Into an Insider ATM – BMF Reports

BMF Reports says Capricor's Nippon deal was a non-binding LOI, with insider sales, stalled DMD trials, and grant-funded dilution.

BMF Reports
Aug 17, 2026